Injections of semaglutide were associated with significant improvement in cognitive function in people living with HIV (PWH), ...

BRP, identified through peptide prediction, may revolutionize weight loss treatment, offering efficacy without the ...

Ozempic contains the active ingredient semaglutide. (An active ingredient is what makes a drug work.) It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists.

Now that the shortage of semaglutide injection products has been resolved, the Food and Drug Administration (FDA) will restrict third parties ...

The Post talked to three people taking semaglutide, plus one weight loss doctor, to find out what’s motivating them to stay mum. Jennifer*, a 50-something from New Jersey, has lost 40 lbs.

On February 21, 2025, the US Food and Drug Administration (FDA) revised its shortage categorization of semaglutide, a glucagon-like peptide 1 ...

according to the Centers for Disease Control and Prevention (CDC), the weight loss drug known as semaglutide has become more popular. This medication is a glucagon-like peptide-1 (GLP-1 ...

Compounders are on alert after the US Food and Drug Administration (FDA) declared the shortage of semaglutide –the active ingredient in glucagon-like peptide 1 receptor agonist (GLP-1RA ...

The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022. The FDA's announcement comes months after drugmaker Novo Nordisk told the agency ...

Semaglutide is a glucagon-like peptide-1 receptor agonist. Also known simply as GLP-1 agonists, these drugs help manage blood sugar levels and weight. Ozempic is approved by the Food and Drug ...

One of the peptide products is glucagon-like peptide 1, or GLP-1, which regulates appetite and blood sugar levels; semaglutide works by mimicking the effect of GLP-1 in the body. The team turned to ...

Glucagon like peptide medications also known as GLP-1s is a medicine group that helps lower blood sugar in people with ...